MIDATECH PHARMA
MIDATECH PHARMA
Investors
Investors
Shareholder Information

Shareholder Meeting Notices

Date Title Document Webcast
12/02/2020 Shareholder Circular and Notice of General Meeting to be held on 2 March 2020
19/06/2019 Notice of 2019 AGM
05/02/2019 Shareholder Circular, Open Offer & Notice of General Meeting Panel Waiver
28/09/2018 Shareholder Circular and Notice of General Meeting to be held on 15 October 2018
13/08/2018 Notice of 2018 AGM
28/09/2017 Notice of General Meeting to be held on 16 October 2017
11/04/2017 Notice of Annual General Meeting 2017
12/10/2016 Notice of General Meeting to be held on 28 October 2016
11/05/2016 Notice of 2016 AGM
21/05/2015 Notice of 2015 AGM
Share Detail
Number of shares 63,048,852
Country of listing UK / US
Status AIM Listed / NASDAQ Listed
Index FTSE AIM All Share / NASDAQ
FTSE Sector Pharmaceutical & Biotechnology
FTSE sub-sector Biotechnology
Ticker MTPH / MTP
CUSIP GB00BKT14T00

The percentage of 0.1p Ordinary shares not being held in public hands is 74%

Shares held in treasury: Nil.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 19 August 2020.

Major Shareholders

Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.

Name Number of shares %
CMS Medical Venture Investment (HK) Limited* 5,194,805 8.2
A&B (HK) Company Limited* 5,194,805 8.2
Lombard Odier Asset Management (Europe) Limited 5,555,556 8.8

* CMS Medical Venture Investment (HK) Limited and A&B (HK) Company Limited are considered a Concert Party

Information correct as at 19 August 2020.

ADR Information
Ticker Structure Exchange Ratio DR ISIN CUSIP
MTP Level III ADR NASDAQ 1 ADR : 5 Ordinary Shares US59564R3021 59564R302